Clinical Trials in New York

Showing 8381-8400 of 22,668 trials

InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O )

NCT04426201

Comparison of the effects of CYT107 vs Placebo administered IM at 10μg/kg twice a week for three weeks on immune reconstitution of lymphopenic COVID-19 patients

COVID-19Lymphocytopenia

Revimmune10 participantsStarted Dec 2020

New York, New York, United States • Houston, Texas, United States

COMPLETEDPhase 1< 1 mile

Refining Cough Skill Training in Parkinson's Disease and Dysphagia

NCT05700838

Airway protection deficits (cough and swallowing) are prevalent and pervasive in Parkinson's disease (PD), contributing to adverse health outcomes like pneumonia. This study aims to refine cough skill training by examining whether variable versus constant practice conditions improve cough outcomes in people with PD. In addition, this study will provide insight into optimal respiratory adaptations that occur during training to support cough effectiveness, resulting in immediately translatable treatments to improve airway protection-related health outcomes in people with neurodegenerative disease.

Parkinson DiseaseDysphagia

Teachers College, Columbia University23 participantsStarted Sep 2022

New York, New York, United States

RECRUITINGPhase 1/2< 1 mile

Phase I/IIa Study of H002 in NSCLC With Active EGFR Mutation

NCT05519293

This is a phase I/IIa, open-label, dose-escalation and expansion study to evaluate the safety, tolerability, PK and preliminary anti-tumor activity of H002 when given orally in patients with active EGFR mutation locally advanced or metastatic non-small cell lung cancer (NSCLC). The study will contain two parts: Part A is dose escalation phase (i.e., Phase I) and Part B is dose expansion phase (i.e., Phase IIa).

Non-small Cell Lung Cancer

RedCloud Bio76 participantsStarted Dec 2022

Los Angeles, California, United States • Boston, Massachusetts, United States • New York, New York, United States +1 more locations

InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O )

Refining Cough Skill Training in Parkinson's Disease and Dysphagia

Phase I/IIa Study of H002 in NSCLC With Active EGFR Mutation

Find Trials by Condition in New York

Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar Pain

A Maintenance Therapy Study of Odetiglucan With CDX-1140 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma

A SAD/MAD to Assess the Safety, PK/PD of FT-4202 in Healthy Volunteers and Sickle Cell Disease Patients

Visceral Manifold Study for the Repair of Thoracoabdominal Aortic Aneurysms

Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration

A Study of Olaparib and Durvalumab in Prostate Cancer

Open-Label Extension Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome

mHealth Mindfulness With Patients With Serious Illness and Their Caregivers

An Observational Study to Learn More About the Use of Androgen Receptor Inhibitors and How They Affect Men With Nonmetastatic Prostate Cancer in Routine Medical Care in the United States

Topical Scalp Psoriasis Study Evaluating Topicort Topical Spray

Evaluation of Product Performance of a New Silicone Hydrogel Multifocal Contact Lens

Immunogenicity, Safety and Tolerability of the Typhoid Fever Vaccine Candidate M01ZH09 in Healthy Adults

Study to Evaluate the Safety and Pharmacokinetics of Efmarodocokin Alfa in Combination With Standard of Care in Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Study Evaluating Safety, Tolerability and Clinical Activity of GSK2857916 in Combination With Pembrolizumab in Subjects With Relapsed/Refractory Multiple Myeloma (RRMM)

A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF)

Lyophilized Fecal Microbiome Transfer vs. Vancomycin Monotherapy for Primary Clostridioides Difficile Infection